Ftse Mib
33.354,69
-0,95%
DAX
18.163,52
-0,41%
S&P 500
5.464,62
-0,16%
NASDAQ
17.699,26
-0,13%
Bitcoin
64.241,41
-0,89%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Innovate Biopharmaceuticals Inc (INNT) Innovate Biopharmaceuticals Inc (INNT) Notizie

INNT

Innovate Biopharmaceutic... (INNT)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:INNT
DataOraFonteTitoloSimboloCompagnia
13/11/201914:00PR Newswire (US)RDD Pharma Enters into Non-Binding Letter of Intent to Acquire Naia Rare Diseases, Strengthening Gastroenterology Orphan Dise...NASDAQ:INNTInnovate Biopharmaceuticals Inc
08/11/201922:14Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:INNTInnovate Biopharmaceuticals Inc
07/11/201922:46Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:INNTInnovate Biopharmaceuticals Inc
07/10/201913:00Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INNTInnovate Biopharmaceuticals Inc
28/08/201900:41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INNTInnovate Biopharmaceuticals Inc
13/08/201915:00GlobeNewswire Inc.Innovate Biopharmaceuticals, Inc. Announces First Patient Dosed in the First Phase 3 Clinical Trial for Patients with Celiac ...NASDAQ:INNTInnovate Biopharmaceuticals Inc
08/08/201922:30GlobeNewswire Inc.Innovate Biopharmaceuticals Reports Second Quarter 2019 Results and Corporate UpdatesNASDAQ:INNTInnovate Biopharmaceuticals Inc
15/07/201923:30GlobeNewswire Inc.Innovate Biopharmaceuticals Announces Corporate Update and Expected Date for Second Quarter Earnings ReleaseNASDAQ:INNTInnovate Biopharmaceuticals Inc
15/07/201912:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:INNTInnovate Biopharmaceuticals Inc
03/07/201923:04Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:INNTInnovate Biopharmaceuticals Inc
03/07/201923:03Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:INNTInnovate Biopharmaceuticals Inc
24/06/201913:00GlobeNewswire Inc.Innovate Biopharmaceuticals Expands Its Management team with the Addition of Ed Sitar as Its Chief Financial OfficerNASDAQ:INNTInnovate Biopharmaceuticals Inc
10/06/201914:01GlobeNewswire Inc.Innovate Biopharmaceuticals Announces the Start of the First Phase 3 Clinical Trial in Celiac DiseaseNASDAQ:INNTInnovate Biopharmaceuticals Inc
31/05/201922:05Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:INNTInnovate Biopharmaceuticals Inc
20/05/201915:45GlobeNewswire Inc.Innovate Biopharmaceuticals Announces Presentation of Three Posters Focusing on the Molecular Biology and Pharmacology of Lar...NASDAQ:INNTInnovate Biopharmaceuticals Inc
17/05/201922:54Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:INNTInnovate Biopharmaceuticals Inc
09/05/201914:01GlobeNewswire Inc.Innovate Biopharma Announces Analyst Event on Monday, May 20, 2019, in San DiegoNASDAQ:INNTInnovate Biopharmaceuticals Inc
01/05/201922:30GlobeNewswire Inc.Innovate Biopharmaceuticals Announces Closing of $8.7 Million Registered Direct OfferingNASDAQ:INNTInnovate Biopharmaceuticals Inc
01/05/201915:12Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:INNTInnovate Biopharmaceuticals Inc
29/04/201919:19GlobeNewswire Inc.Innovate Biopharmaceuticals Announces $8.7 Million Registered Direct Offering Priced At-the-MarketNASDAQ:INNTInnovate Biopharmaceuticals Inc
29/04/201913:35GlobeNewswire Inc.Innovate Biopharmaceuticals Shows Larazotide is the First Drug, with its Novel Mechanism of Action of Re-normalizing the Inte...NASDAQ:INNTInnovate Biopharmaceuticals Inc
26/04/201923:15Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:INNTInnovate Biopharmaceuticals Inc
26/04/201918:59GlobeNewswire Inc.Innovate Biopharmaceuticals First Quarter 2019 Financial Results and Operational Progress Updates - Webcast DetailsNASDAQ:INNTInnovate Biopharmaceuticals Inc
11/04/201915:45GlobeNewswire Inc.Innovate Biopharmaceuticals Presents Oral Poster at European Association for the Study of the Liver (EASL) Demonstrating Posi...NASDAQ:INNTInnovate Biopharmaceuticals Inc
02/04/201913:00GlobeNewswire Inc.Innovate Biopharmaceuticals to Announce First Quarter 2019 Financial Results and to Provide Operational Progress Updates on A...NASDAQ:INNTInnovate Biopharmaceuticals Inc
26/03/201914:32GlobeNewswire Inc.Innovate Biopharmaceuticals Announces Collaboration with Institut Gustave Roussy to Study Regulation of Intestinal Permeabili...NASDAQ:INNTInnovate Biopharmaceuticals Inc
19/03/201912:45GlobeNewswire Inc.Innovate Biopharmaceuticals Reports Financing to Initiate the First Phase 3 Clinical Trial in Celiac Disease, Fiscal Year 201...NASDAQ:INNTInnovate Biopharmaceuticals Inc
19/03/201900:30GlobeNewswire Inc.Innovate Biopharmaceuticals to Discuss Fourth Quarter and Full Year 2018 Financial Results and to Provide Corporate and Opera...NASDAQ:INNTInnovate Biopharmaceuticals Inc
18/03/201922:18Edgar (US Regulatory)Annual Report (10-k)NASDAQ:INNTInnovate Biopharmaceuticals Inc
18/03/201913:51GlobeNewswire Inc.Innovate Biopharmaceuticals Announces Entry Into Securities Purchase Agreement to Fund Initiation of the First Phase 3 Celiac...NASDAQ:INNTInnovate Biopharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:INNT

La tua Cronologia

BIT
UC7Z1S
Unicredit Bank
USOTC
ALPMY
Astellas Pharma (PK)
TG
A1ZX3L
Bombardier
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network